119th Congress · introduced in the House · Jan 28, 2025
Stop Chinese Fentanyl Act of 2025
Official title from Congress.gov
Latest action (Sep 3, 2025): Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
View on Congress.govPolicy area: International Affairs
Congressional Research Service summary, version: Introduced in House (Jan 28, 2025)
Stop Chinese Fentanyl Act of 2025
This bill subjects certain Chinese entities and government officials to potential sanctions related to opioid trafficking and requires the President to conduct certain preliminary analyses before regulating economic transactions in the event of a national emergency related to international drug trafficking.
Specifically, for the purposes of the Fentanyl Sanctions Act, the bill changes the definition of foreign opioid trafficker to specify that the term includes (1) Chinese entities involved in the production or sale of synthetic opioids or related pharmaceutical ingredients that fail to take steps to detect or prevent opioid trafficking; and (2) certain senior Chinese government officials that aid and abet opioid trafficking, including through intentional inaction. Under current law, the President must impose certain sanctions on individuals and entities identified as foreign opioid traffickers.
Further, the bill extends through 2029 an existing requirement that the President report to Congress annually on identified foreign opioid traffickers and any sanctions imposed on them. (This requirement expired in December 2024.)
The bill also requires the President to take additional steps in issuing regulations under the International Emergency Economic Powers Act (IEEPA) pursuant to a declared national emergency related to international drug trafficking. (IEEPA authorizes the President to regulate a variety of economic transactions following a declaration of national emergency.) Under the bill, the President must evaluate the costs and benefits of issuing economic regulations for the purpose of resolving the drug trafficking emergency and publish a discussion of such costs and benefits.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
House · Sep 2, 2025 · Roll call 220 · Passed
Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220). (text: CR H3728-3729) Roll call details
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220). Roll call details
Considered as unfinished business. (consideration: CR H3741-3742)
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
DEBATE - The House proceeded with forty minutes of debate on H.R. 747.
Considered under suspension of the rules. (consideration: CR H3728-3731)
Mr. Baumgartner moved to suspend the rules and pass the bill, as amended.
Ordered to be Reported in the Nature of a Substitute by Voice Vote.
Committee Consideration and Mark-up Session Held
Reported (Amended) by the Committee on Financial Services. H. Rept. 119-19, Part I.
Reported (Amended) by the Committee on Financial Services. H. Rept. 119-19, Part I.
Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
Asia · China · Civil actions and liability · Congressional oversight · Drug trafficking and controlled substances · Presidents and presidential powers, Vice Presidents · Sanctions · Smuggling and trafficking
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCommittee Consideration and Mark-up Session Held
Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, Oversight and Government Reform, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, Oversight and Government Reform, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, Oversight and Government Reform, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, Oversight and Government Reform, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
Coverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
3 citations.
FDD ACTION · lobbying firm or registrant: FDD ACTION
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Banking
$170,000
Spent on own lobbying
…s (SEVER) Act, all provisions. H.R. 5606, Return to Palestinian Entities Accountability and Counterterrorism Enforcement (Return to PEACE) Act, all provisions. H.R. 747, Stop Chinese Fentanyl Act of 2025, all provisions. S. 1241, Sanctioning Russia Act of 2025, all provisions. S. 1969, AFIDA Improvements Act of 2025, all provi…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FDD ACTION · lobbying firm or registrant: FDD ACTION
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 21, 2025 · issue area: Banking
$170,000
Spent on own lobbying
…9, Upholding the Dayton Peace Agreement Through Sanctions Act, all provisions. H.R. 4397, Muslim Brotherhood Terrorist Designation Act of 2025, all provisions. H.R. 747, Stop Chinese Fentanyl Act of 2025, all provisions. H.Res. 139, Calling on the United Kingdom, France, and Germany (E3) to initiate the snapback of sanctions o…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FDD ACTION · lobbying firm or registrant: FDD ACTION
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 21, 2025 · issue area: Banking
$150,000
Spent on own lobbying
…t Association Act, all provisions. H.R. 1800, Solidify Iran Sanctions Act, all provisions. H.R. 2012, Iran Sanctions Relief Review Act of 2025, all provisions. H.R. 747, Stop Chinese Fentanyl Act of 2025, all provisions. H.R.1474, International Nuclear Energy Financing Act of 2025, all provisions. H.R.2384, Financial Technolog…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing